GMAB Non-viral, Cell-penetrating Gene Monoclonal Antibody Platform: A Highly Targeted and Unique Approach for Delivery of Therapeutic Nucleic Acids
Time: 11:30 am
day: Track B - Day 2 AM
Details:
- Non-covalent binding and protection of both RNA and DNA payloads
- Selective targeting of ENT2 transporter and cell penetration into cytoplasm and nucleus
- Systemic delivery of nucleic acid payloads to ENT2 positive tissues in vivo
- Optionality for therapeutic nucleic acid targeting in treatment of cancer and musculoskeletal disease
